AutoImmune has reported a net loss of $56,000, or break even per share basic and diluted, for the three months ended December 31, 2007, compared with a net profit of $36,000, or break even per share basic and diluted, for the three months ended December 31, 2006.
Subscribe to our email newsletter
For the year ended December 31, 2007, the net loss was $118,000, or $0.01 per share basic and diluted, compared with net loss of $481,000, or $0.03 per share basic and diluted for the same period in 2006.
Robert Bishop, CEO of AutoImmune, said: “Product sales at Colloral, our joint venture with Deseret Laboratories, were up from the third quarter, but results were down compared to the fourth quarter of last year.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.